Effect of malunggay (Moringa oleifera) capsules on lipid and glucose levels
Acta Medica Philippina
;
: 22-27, 2013.
Article
in English
| WPRIM
| ID: wpr-633655
ABSTRACT
OBJECTIVES:
To determine the effect of malunggay leaf capsules on LDL (primary efficacy outcome measure); weight, BMI, FBS, serum glucose 2 hours after a 75 g oral glucose load, cholesterol, HDL and triglycerides (secondary efficacy outcome measures); creatinine, ALT and CBC (secondary safety outcome measures); and to determine if these are associated with adverse events. STUDYDESIGN:
randomized controlled trialPARTICIPANTS:
Seventy nine Filipinos, 18-55 years old with LDL>2.6 mmol/L (100 mg/dL) but of low cardiovascular risk were randomized into malunggay and placebo groups. INTERVENTION Malunggay capsules for 30 days versus placeboRESULTS:
33 and 35 participants in the malunggay and placebo groups, respectively, completed the treatment. There was a reduction of 13.76 mg/dL in the LDL of the malunggay group, compared to a 19.28 mg/dL reduction in the placebo group (p=0.564).CONCLUSION:
Malunggay leaf capsules given for 30 days among adults with serum LDL >2.6 mmol/L (100 mg/dL) but with low cardiovascular risk decreased LDL levels to the same degree as placebo. There were no significant differences in the change in the secondary efficacy and safety outcome measures, and in the occurence of adverse events.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Triglycerides
/
Body Weight
/
Capsules
/
Cardiovascular Diseases
/
Body Mass Index
/
Risk Factors
/
Creatinine
/
Glucose
/
Cholesterol, HDL
/
Lipoproteins, LDL
Type of study:
Controlled clinical trial
/
Etiology study
/
Risk factors
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
Language:
English
Journal:
Acta Medica Philippina
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS